Authors | Clinical outcomes |
---|---|
Balsom C. [24] | Cognitive performance*, depression*, pain*, social engagement, health status, and activities of daily living |
Survival | |
Boyé NDA. [25] | Time since the first fall* |
Time since the second fall* | |
Campbell NL. [26] | Delirium severity* |
Mortality rate | |
Falls number* | |
Pressure ulcer* | |
Cateau D. [28] | Number of complaints |
QoL | |
Falls number* | |
Mortality rate | |
Cateau D. [29] | Falls number per resident* |
Falls number per year* | |
Mortality rate | |
Curtin D. [32] | Falls number* |
Nonvertebral fracture number* | |
QoL | |
Death number | |
Dalleur O. [33] | Clinical relevance |
Eveleigh R. [35] | General distress and depressive symptoms* |
Somatic comorbidity* | |
Gedde MH. [36] | Behavioral and psychological symptom of dementia* |
Activities of daily living | |
Gulla C. [38] | Blood pressure* |
Death number | |
Hah JM. [39] | Adverse drug reactions* |
Time to surgical recovery | |
Time to pain cessation* | |
Ee C.[40] | Constipation* |
Other symptom recurrence | |
Adverse drug withdrawal events | |
Kersten H. [41] | Cognitive function* |
Mouth dryness* | |
Kua CH. [42] | Fall rate* |
Fall risk* | |
Functional status | |
Mortality rate | |
Cognitive status* | |
Potter K. [45] | Falls number* |
Nonvertebral fracture number* | |
Cognitive function* | |
Physical function* | |
Bowel function* | |
QoL | |
General health | |
Sleep quality* | |
Survival | |
Rieckert A. [46] | Composite outcome: death + system outcome |
Mortality cause | |
Falls number* | |
Recorded fractures number* | |
Adverse drug reactions | |
QoL | |
Sathienluckana T. [47] | Cognitive function* |
Psychiatric symptoms* | |
Proportions of patients who had a clinical response of psychopathological symptoms* | |
Smeets CHW. [48] | Neuropsychiatric symptoms* |
Sullivan MD. [49] | Pain severity* |
QoL | |
Anxiety* | |
Insomnia* | |
Confidence in ability to do tasks and activities despite pain | |
Somatic symptom severity* | |
Opioid craving* | |
Patient global impression of change | |
Van der Meer HG. [52] | Anticholinergic side effect* |
Sedative side effect* | |
Fall risk* | |
Cognitive function* | |
Activities of daily living | |
QoL | |
Vicens C. [53] | Anxiety* |
Depression* | |
Sleep satisfaction* | |
Withdrawal symptoms* | |
Alcohol consumption | |
Vicens C. [54] | Anxiety* |
Depression* | |
Sleep satisfaction* | |
Wong APY. [55] | Recurring or worsering symptoms* |
Death number | |
Wouters H. [56] | Falls number* |
Cognitive function* | |
Neuropsychiatric symptoms* | |
QoL | |
Zechmann S. [57] | Symptom scores* |
Unexpected clinical events | |
QoL | |
Death number |